Zoetis | ZTS - Current Assets


Zoetis reported $6.47B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
Align Technology USD 2.66B 7.62M Jun/2026
Bayer EUR 35.3B 2.39B Mar/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Coherus Biosciences USD 133.79M 72.25M Jun/2026
Dentsply International USD 1.85B 178M Mar/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
Henry Schein USD 4.6B 104M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Illumina USD 2.83B 96M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
J&J USD 59.77B 601M Jun/2026
Laboratory Of America USD 3.81B 743.9M Jun/2026
Merck USD 35.02B 8.5B Mar/2026
Neogen USD 604.6M 14.6M Mar/2026
Pacira USD 615.21M 100.25M Jun/2026
Perrigo USD 2.45B 260.7M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Quest Diagnostics USD 2.84B 278M Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Sanofi EUR 30.16B 789M Mar/2026
Zoetis USD 6.47B 294M Mar/2026